Which diseases are poised to benefit from therapeutic antibody development
Drug Discovery World
NOVEMBER 14, 2023
DDW’s Megan Thomas looks at how different diseases will benefit from the success of therapeutic antibodies. billion in 2021, and is projected to reach $106.8 What is particularly noteworthy when it comes to the mAbs being developed and approved for Covid-19 is drug repurposing, showing the scope of future treatments with mAbs.
Let's personalize your content